Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters

British Journal of Cancer

Volumn 96, Issue 3, 2007, Pages 477-484

  Yun, J P ^a   Miao, J ^b   Chen, G G ^b   Tian, Q H ^a   Zhang, C Q ^a   Xiang, J ^a   Fu, J ^a   Lai, P B S ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

B23; Cell proliferation; Hepatocellular carcinoma; Malignancy; Nucleophosmin; PCNA

Indexed keywords

BIOLOGICAL MARKER; MONOCLONAL ANTIBODY; NUCLEOPHOSMIN; PROTEIN ANTIBODY;

ADULT; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HEMANGIOMA; LIVER HYPERPLASIA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 33846794396     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603574     Document Type: Article

References (46)

1. Bertwistle D, Sugimoto M, Sherr CJ (2004) Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 24: 985-996
2. Borer RA, Lehner CF, Eppenberger HM, Nigg EA (1989) Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56: 379-390
3. Brady SN, Yu Y, Maggi Jr LB, Weber JD (2004) ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol Cell Biol 24: 9327-9338
4. Chang JH, Olson MO (1990) Structure of the gene for rat nucleolar protein B23. J Biol Chem 265: 18227-18233
5. Colombo E, Marine JC, Danovi D, Falini B, Pelicci PG (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 4: 529-533
6. Cordell JL, Pulford KA, Bigerna B, Roncador G, Banham A, Colombo E, Pelicci PG, Mason DY, Falini B (1999) Detection of normal and chimeric nucleophosmin in human cells. Blood 93: 632-642
7. Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y, Beauchamp RD (2001) Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res 61: 5389-5395
8. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, La Starza R, Diverio D, Colombo E, Santucci A, Bigerna B, Pacini R, Pucciarini A, Liso A, Vignetti M, Fazi P, Meani N, Pettirossi V, Saglio G, Mandelli F, Lo-Coco F, Pelicci PG, Martelli MF, GIMEMA Acute Leukemia Working Party (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352: 254-266
9. Feuerstein N, Mond JJ (1987) 'Numatrin', a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J Biol Chem 262: 11389-11397
10. Feuerstein N, Spiegel S, Mond JJ (1988) The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody. J Cell Biol 107: 1629-1642
11. Gao H, Jin S, Song Y, Fu M, Wang M, Liu Z, Wu M, Zhan Q (2005) B23 regulates GADD45a nuclear translocation and contributes to GADD45a-induced cell cycle G2-M arrest. J Biol Chem 280: 10988-10996
12. Gordon S, Akopyan G, Garban H, Bonavida B (2006) Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25: 1125-1142
13. Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP (2005) Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437: 147-153
14. Grisendi S, Mecucci C, Falini B, Pandolfi PP (2006) Nucleophosmin and cancer. Nat Rev Cancer 6: 493-505
15. Hingorani K, Szebeni A, Olson MO (2000) Mapping the functional domains of nucleolar protein B23. J Biol Chem 275: 24451-24457
16. Huang N, Negi S, Szebeni A, Olson MO (2005) Protein NPM3 interacts with the multifunctional nucleolar protein B23/nucleophosmin and inhibits ribosome biogenesis. J Biol Chem 280: 5496-5502
17. Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y (2003) Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 12: 1151-1164
18. Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T, Tanaka N (1997) Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 15: 1275-1281
19. Li J, Zhang X, Sejas DP, Bagby GC, Pang Q (2004) Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J Biol Chem 279: 41275-41279
20. Maiguel DA, Jones L, Chakravarty D, Yang C, Carrier F (2004) Nucleophosmin sets a threshold for p53 response to UV radiation. Mol Cell Biol 24: 3703-3711
21. Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS (2005) Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41: 707-716
22. Miao J, Chen GG, Chun SY, Lai PP (2006) Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression. Cancer Lett 236: 115-124
23. Nozawa Y, Van Belzen N, Van der Made AC, Dinjens WN, Bosman FT (1996) Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 178: 48-52
24. Okuda M (2002) The role of nucleophosmin in centrosome duplication. Oncogene 21: 6170-6174
25. Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K (2000) Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103: 127-140
26. Onda M, Emi M, Yoshida A, Miyamoto S, Akaishi J, Asaka S, Mizutani K, Shimizu K, Nagahama M, Ito K, Tanaka T, Tsunoda T (2004) Comprehensive gene expression profiling of anaplastic thyroid cancers with cDNA microarray of 25 344 genes. Endocr Relat Cancer 11: 843-854
27. Pulford K, Morris SW, Mason DY (2001) Anaplastic lymphoma kinase proteins and malignancy. Curr Opin Hematol 8: 231-236
28. Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, Martelli MF, Haferlach T, Hiddemann W, Falini B (2005) Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 106: 3733-3739
29. Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS, Diehl AM (2006) Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 27: 748-757
30. Spector DL, Ochs RL, Busch H (1984) Silver staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23. Chromosoma 90: 139-148
31. Subong EN, Shue MJ, Epstein JI, Briggman JV, Chan PK, Partin AW (1999) Monoclonal antibody to prostate cancer nuclear matrix protein (PRO: 4-216) recognizes nucleophosmin/B23. Prostate 39: 298-304
32. Szebeni A, Hingorani K, Negi S, Olson MO (2003) Role of protein kinase CK2 phosphorylation in the molecular chaperone activity of nucleolar protein b23. J Biol Chem 278: 9107-9115
33. Takemura M, Ohta N, Furuichi Y, Takahashi T, Yoshida S, Olson MO, Umekawa H (1994) Stimulation of calf thymus DNA polymerase alpha activity by nucleolar protein B23. Biochem Biophys Res Commun 199: 46-51
34. Takemura M, Sato K, Nishio M, Akiyama T, Umekawa H, Yoshida S (1999) Nucleolar protein B23.1 binds to retinoblastoma protein and synergistically stimulates DNA polymerase alpha activity. J Biochem (Tokyo) 125: 904-909
35. Tanaka M, Sasaki H, Kino I, Sugimura T, Terada M (1992) Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer. Cancer Res 52: 3372-3377
36. Tsui KH, Cheng AJ, Chang PL, Pan TL, Yung BY (2004) Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urolog 64: 839-844
37. Umekawa H, Sato K, Takemura M, Watanabe Y, Usui S, Takahashi T, Yoshida S, Olson MO, Furuichi Y (2001) The carboxyl terminal sequence of nucleolar protein B23.1 is important in its DNA polymerase alphastimulatory activity. J Biochem (Tokyo) 130: 199-205
38. Verheggen C, Almouzni G, Hernandez-Verdun D (2000) The ribosomal RNA processing machinery is recruited to the nucleolar domain before RNA polymerase I during Xenopus laevis development. J Cell Biol 149: 293-306
39. Wang D, Umekawa H, Olson MO (1993) Expression and subcellular locations of two forms of nucleolar protein B23 in rat tissues and cells. Cell Mol Biol Res 39: 33-42
40. Weng JJ, Yung BY (2005) Nucleophosmin/B23 regulates PCNA promoter through YY1. Biochem Biophys Res Commun 335: 826-831
41. Wu MH, Chang JH, Yung BY (2002) Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts. Enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression. Carcinogenesis 23: 93-100
42. Yun J, Liew CT, Chew EC, Chan JY (2002) [Expression and relocation of B23 in the process of rat liver cell hyperplasia and liver regeneration]. Zhonghua Yi Xue Za Zhi (Chinese) 82: 974-978
43. Yun JP, Chew EC, Liew CT, Chan JY, Jin ML, Ding MX, Fai YH, Li HK, Liang XM, Wu QL (2003) Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix. J Cell Biochem 90: 1140-1148
44. Yung BY, Busch H, Chan PK (1985) Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. Biochim Biophys Acta 826: 167-173
45. Zeller KI, Haggerty TJ, Barrett JF, Guo Q, Wonsey DR, Dang CV (2001) Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J Biol Chem 276: 48285-48291
46. Zhang Y (2004) The ARF-B23 connection: implications for growth control and cancer treatment. Cell Cycle 3: 259-262